NIH Meeting Starts Later, Still Closed to Everyone
Published Date: 6/11/2026
Notice
Summary
The National Institute of Allergy and Infectious Diseases changed its June 22, 2026 meeting plans. The meeting now starts later at 10:00 a.m., is closed to the public, and has a new lead official, Johanna Schneider. These updates affect anyone following the council’s work and mean no public sessions or new costs are involved.
Analyzed Economic Effects
1 provisions identified: 0 benefits, 1 costs, 0 mixed.
NIAID Meeting Closed; Start Time Shifted
The National Advisory Allergy and Infectious Diseases Council meeting on June 22, 2026, was changed. The meeting will begin at 10:00 a.m. (it had been listed as 8:30 a.m. to 5:00 p.m.) and the full council open session is canceled — the meeting is closed to the public.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-14981, Government Owned Invention Available for License: Nucleophosmin 1 (NPM1) Mutation-Specific T Cell Receptors for Targeted Treatment of Acute Myeloid Leukemia (AML)
The government has developed special T cell receptors that can target a tough type of blood cancer called acute myeloid leukemia (AML), especially in patients with a specific genetic marker. These new receptors promise safer, more precise treatment with fewer side effects than current options. Researchers and companies can now license this invention to help bring this exciting therapy to patients faster.
2026-14964, Center for Scientific Review; Notice of Closed Meeting
The Center for Scientific Review is holding a closed virtual meeting on August 19, 2026, to review neuroscience career development grant applications. This meeting is private to protect sensitive info like trade secrets and personal details. Researchers applying for these grants should note the date, as funding decisions could impact their projects and careers.
2026-14966, Government-Owned Inventions; Availability for Licensing
The National Institutes of Health is offering a new Ebola vaccine invention for companies to license and develop quickly. This vaccine targets the Bundibugyo virus and promises fast and lasting protection, helping stop outbreaks in Central Africa. Businesses interested in licensing should act soon to bring this life-saving tech to market and can contact NIH for details.
2026-14980, Government Owned Invention Available for License: Pigment Epithelium-Derived Factor Peptides and Their Use for Treating Retinal Degeneration
The National Eye Institute has a cool new invention using special peptides to help protect eyes from inherited diseases like retinitis pigmentosa, which causes vision loss for over 100,000 Americans. They’re looking for partners to help develop easy-to-use eyedrops or gene therapy to slow down or stop this eye damage. This could bring hope and new treatments to many people with few options, and interested parties can start talking to the NIH now!
2026-14848, Prospective Grant of an Exclusive Patent License: RXFP1 AGONISTS
The National Institutes of Health plans to give Modala Bio an exclusive license to use new RXFP1 agonist inventions that could help treat diseases like cancer, heart failure, and fibrosis. This means Modala Bio gets special rights to develop and sell these promising medicines worldwide. If you want to comment or apply for a license, you have until August 24, 2026, so don’t miss out!
2026-14752, Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in August 2026 to review and evaluate important grant and contract proposals. These meetings protect private info and trade secrets while deciding who gets funding to fight antibiotic resistance, support schizophrenia research, and boost medical tech. If you’re involved in these fields, keep an eye on these dates—they could impact future research dollars and projects.
Previous / Next Documents
Previous: 2026-11768, Meeting of the Public Safety Officer Medal of Valor Review Board
The Public Safety Officer Medal of Valor Review Board is meeting on June 30, 2026, to review nominations for the 2024-2025 awards and decide who should receive this top honor. This meeting affects public safety officers nominated for their brave actions and helps make sure the best heroes get recognized. The meeting is by phone and closed to the public, with no direct cost impact.
Next: 2026-11774, Agency Information Collection Activities: Extension, Without Change, of a Currently Approved Collection: Generic Clearance for the Collection of Qualitative Feedback on Agency Service Delivery
ICE is extending a current info collection that helps them gather feedback on how well they deliver services—no changes, just more time. This affects the public and other federal agencies who might share their thoughts. Comments are open until August 10, 2026, and there’s no new cost or extra work involved.